Stoke Therapeutics GAAP EPS of -$0.66 beats by $0.02, revenue of $2.91M beats by $0.19M

Nov. 14, 2022 8:31 AM ETStoke Therapeutics, Inc. (STOK)By: Meghavi Singh, SA News Editor
  • Stoke Therapeutics press release (NASDAQ:STOK): Q3 GAAP EPS of -$0.66 beats by $0.02.
  • Revenue of $2.91M beats by $0.19M.
  • As of September 30, 2022, Company had $252.2M in cash, cash equivalents, marketable securities, and restricted cash, anticipated to fund operations into 2025.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.